Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
Pulmonary arterial hypertension is a complex disease resulting from the interplay of myriad biological and environmental processes that lead to remodeling of the pulmonary vasculature with consequent pulmonary hypertension. Despite currently available therapies, there remains significant morbidity a...
Main Authors: | Anna Hemnes, Alexander M.K. Rothman, Andrew J. Swift, Lawrence S. Zisman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-11-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894020957234 |
Similar Items
-
Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
by: Anna R. Hemnes, et al.
Published: (2017-12-01) -
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension
by: Omar A Minai
Published: (2014-01-01) -
Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency
by: Jessica Huston, et al.
Published: (2020-04-01) -
The role of miR-140-5p in humans and animal models of pulmonary arterial hypertension
by: Rothman, Alexander M. K.
Published: (2015) -
Reduced free-living activity levels in pulmonary arterial hypertension patients
by: Stephen J. Halliday, et al.
Published: (2018-11-01)